Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
IPO News

| More

Innova Captab files DRHP with SEBI to raise funds via IPO

Posted On: 2022-06-30 08:37:13 (Time Zone: IST)


Innova Captab, an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution and marketing and exports has filed its Draft Red Herring Prospectus (DRHP) with the markets regulator, Securities and Exchange Board of India (SEBI), to raise funds through an initial public offering (IPO).

The issue with a face value of Rs 10 per equity share consists of a fresh issue of equity shares worth up to Rs 400 crore and an offer-for-sale (OFS) up to 9,600,000 equity shares by Promoter and selling shareholders, which comprises of up to 3,200,000 by Manoj Kumar Lohariwala, up to 3,200,000 by Vinay Kumar Lohariwala (Promoter Selling Shareholders) and up to 3,200,000 by Gian Parkash Aggarwal (Other Selling Shareholders).

Market source estimate it to raise anywhere between Rs 700-900 cr.

The Offer is being made through the Book Building Process, wherein not more than 50% of the Offer shall be available for allocation to Qualified Institutional Buyers, not less than 15% of the Offer shall be available for allocation to Non-Institutional Bidders and not less than 35% of the Offer shall be available for allocation to Retail Individual Bidders.

The company, in consultation with the lead bankers to the issue may consider a private placement or preferential issue of equity shares or any other method aggregating up to Rs 80 crore. If such placement is completed, the fresh issue size will be reduced.

The proceeds from its fresh issuance worth Rs. 180.50 crore will be utilised for repayment and/or prepayment, in part or in full, of certain outstanding loans, Rs 29.50 crore for investment in subsidiary, UML, for repayment and / or prepayment in part or full of an outstanding loan availed, Rs 90 crore for funding working capital requirements and for general corporate purposes.

The Haryana based drugmaker, in terms of operating revenue, was the second largest formulation CDMO in India in Fiscal 2021 and the third fastest growing formulation contract development and manufacturing organization ("CDMO") over the period Fiscal 2019 to Fiscal 2021. Its business includes contract development and manufacturing organization business providing manufacturing services to Indian pharmaceutical companies, domestic branded generics business and an international branded generics business.

According to a CRISIL report quoted in the DRHP, fourteen of the top fifteen largest Indian pharmaceutical companies in the domestic formulation market are its customer. For the nine months ended December 31, 2021, it had 164 CDMO customers, some of its key customers include Cipla Limited, Glenmark Pharmaceuticals Limited, Wockhardt Limited, Corona Remedies Private Limited, Emcure Pharmaceuticals Limited, Lupin Limited, Intas Pharmaceuticals Limited, Leeford Healthcare Limited, Medley Pharmaceuticals Limited, Cachet Pharmaceuticals Limited, Eris Healthcare Private Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Oaknet Healthcare Private Limited, Zuventus Healthcare Limited, Ajanta Pharma Limited, Mankind Pharma Limited and Smart Laboratories Private Limited.

Its main competitors are Suven Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Ajanta Pharma Limited, Eris Lifesciences Limited, Indoco Remedies Limited, J. B. Chemicals and Pharmaceuticals Limited, Laurus Labs Limited, NATCO Pharma Limited and Windlas Biotech Limited.

Innova Captab has an extensive network of over 96,000 retail pharmacies and above 3,400 distributors and stockists, with a diverse generics product portfolio manufacturing in excess of 400 items and markets under its own brands in the Indian market and exports its branded generic products to 17 countries.

The company has two manufacturing facilities in Baddi, Himachal Pradesh and a new facility to come up in Jammu. Its facilities have good manufacturing practises ("GMP") certifications from the Himachal Pradesh Health and Family Welfare Department, in accordance with the format advised by the World Health Organization (the "WHO"), the GMP for medicines intended for the European Union market ("EU-GMP"), and Ethiopia.

The companies revenue from operations grew 10% to Rs 410.66 crore for Fiscal 2021 from Rs 373.32 crore for the same period last year, and profit after tax grew 23.70% to Rs 34.50 crore for Fiscal 2021 from Rs 27.89 crore for Fiscal 2020. For nine month ending December 2021, revenue from operations stood at Rs 584.12 crore and profit after tax at Rs 50.88 crore.

The Indian CDMO market grew at a CAGR of 14% from fiscal 2016 to fiscal 2020, and is expected to continue in the next five years from fiscal 2021 to fiscal 2026 on the back of strong growth sustained by the global pharmaceutical industry and rise in India's export potential, it is projected that the Indian CDMO market (including domestic and exports) to grow at a CAGR of approximately 14-16% from Rs. 1.01 trillion in fiscal 2021 to Rs. 2.0 to 2.05 trillion in fiscal 2026.

ICICI Securities Limited and JM Financial Limited are the book running lead managers and KFin Technologies Limited is the registrar to the offer. The equity shares are proposed to be listed on BSE and NSE.


Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Icon Facilitators Announces BSE SME IPO Approval, Targets ?22 Crore Fundraise

Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO

Leading Decorative Wall Panel & Premium Laminates Brand Euro Pratik files DRHP for Rs 730 crore IPO

P S Raj Steels Receives In-Principal Approval for IPO on NSE Emerge

Jesons Industries refiles DRHP with Sebi for IPO

Standard Glass Lining Technology Limited raises Rs 123 crores from Anchor Investors

Greaves Electric Mobility Limited files DRHP for IPO

Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2

Senores Pharmaceuticals IPO fully subscribed on Day 1

Speciality Fabric Manufacturer Rachit Prints files DRHP with BSE SME

Eleganz Interiors Limited files DRHP with NSE Emerge

Jungle Camps India Limited plans to raise around Rs. 30 crores from IPO

Afcons Infrastructure Ltd's IPO to open on Friday, October 25, 2024, price band set at ₹440/- to ₹463/- per Equity Share

Senores Pharmaceuticals gets Sebi nod for IPO

Telangana-based Standard Glass Lining Technology Limited gets Sebi nod for IPO

Dr. Agarwal's Health Care files DRHP for IPO

Icon Facilitators Limited files DRHP with BSE SME

Casagrand Premier Builder Limited files DRHP for Rs 1,100 crore IPO

Manba Finance Limited raises Rs. 45.25 crore from Anchor Investors

NTPC Green Energy Ltd files DRHP for IPO

Influx Healthtech Limited Files DRHP with NSE Emerge

Gala Precision Engineering IPO subscribed 201.41 times on Final Day, the most since the start of FY25

Identical Brains Studios Limited files DRHP with NSE Emerge

Gala Precision Engineering Ltd's IPO to open on Monday, September 02, 2024, price band set at ?503/- to ?529/- per Equity Share

Sanstar Limited IPO subscribed 82.98 times on Final Day

Sanstar Ltd's IPO to open on Friday, July 19, 2024, price band set at ?90/- to ?95/- per Equity Share

Three M Paper Boards Ltd's SME IPO to open on Friday, July 12, 2024

Virtual Galaxy Infotech attracts marquee investors, raises Rs 21.44 Crore ahead of IPO Launch

IT Solutions provider Orient Technologies gets Sebi nod for IPO

Accel and Flipkart-backed Zinka Logistics Solutions Limited files DRHP for IPO

Sleepwear-focused company S D Retail Limited files DRHP for SME IPO

ACME Solar Holdings Limited files DRHP for Rs 3,000 crore IPO

Nephro Care India Makes History - First SME IPO to Surpass Rs. 20,000 Crore in bids

Gala Precision Engineering gets Sebi nod for IPO

Noida-based Interarch Building Products Limited gets SEBI nod for IPO

Shivalik Engineering Industries Limited files DRHP for IPO

Niva Bupa files for Rs 3,000Cr IPO

Sagility India Limited files DRHP for IPO

Ambey Laboratories Ltd IPO to open for subscription on July 4, 2024

Nephro Care India Limited IPO opened today, Anchor Book fully subscribed

Allied Blenders & Distillers IPO subscribed 23.49 times on Final Day

Allied Blenders & Distillers IPO fully subscribed on Day 2

Allied Blenders & Distillers IPO subscribed 51% on Day 1

Stanley Lifestyles IPO subscribed 95.75 times on Final Day

Deepak Parekh-backed Nephro Care India Limited's IPO opens on Friday, June 28

Allied Blenders & Distillers Limited raises Rs. 449.1 crore from Anchor Investors

Stanley Lifestyles IPO subscribed 5.22 times on Day 2

Mason Infratech Limited IPO Opens on June 24, 2024

Stanley Lifestyles IPO fully subscribed on Day 1 led by strong retail, NII demand

Stanley Lifestyles Limited raises Rs. 161.10 crore from Anchor Investors


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020